Atara Biotherapeutics, Inc. (ATRA) insider trading

By person

16 insiders · 0 transactions

Insider

Role

Bought

Sold

Net

Holding

Worth

Change

EcoR1 Capital, LLC entity

10% owner

—

1,552,000

$14.90M

+48.6%

Adiumentum Capital Fund I LP entity

Director

—

1,209,395

$11.61M

+6.7%

Panacea Innovation Ltd entity

10% owner

—

1,011,000

$9.71M

−1.2%

Redmile Group, LLC entity

Director

—

636,852

$6.11M

+44.2%

Brian N Cherry

Director

—

166,486

$1.60M

+334.5%

AnhCo Nguyen

President and CEO

—

132,775

$1.27M

+67.8%

Pascal Touchon

Director

—

77,955

$748.37K

+11.2%

Eric J Hyllengren

Former EVP, CFO & COO

—

56,231

$539.82K

+127.1%

Yanina Grant-Huerta

Chief Accounting Officer

—

49,636

$476.51K

+25.1%

William K Heiden

Director

—

34,188

$328.20K

+138.1%

Carol Giltner Gallagher

Director

—

33,012

$316.92K

+31.1%

Matthew K Fust

Director

—

30,188

$289.80K

+191.4%

Jill Henrich

EVP, Chief Regulatory Officer

—

18,679

$179.32K

−9.9%

Maria Grazia Roncarolo

Director

—

17,368

$166.73K

+82.1%

Ameet Mallik

Director

—

16,928

$162.51K

+86.0%

Gregory Austin Ciongoli

Director

—

12,000

$115.20K

—

No percentages here. These insiders hold more than one class of share between them, and the share count on file covers one of them rather than all. Dividing the two would compare different things.

Atara Biotherapeutics, Inc.

What the insiders did No buying or selling

By person